Top Markets
Coin of the day
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Classifica tra le azioni #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Prezzo delle azioni
$2.37
Ultima sincronizzazione: 2025-12-15
Capitalizzazione di mercato
$3.99M
Variazione (1 giorno)
-5.58%
Variazione (1 anno)
24.74%
Paese
US
Scambia Qualigen Therapeutics, Inc. (QLGN)

Categoria

Cronologia dei frazionamenti azionari per Qualigen Therapeutics, Inc. (QLGN)
L’azione Qualigen Therapeutics, Inc. (simbolo: QLGN) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 16, 2026.
Una quota di QLGN acquistata prima di Aug 16, 2026 equivale oggi a 0 quote di QLGN.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE